News
DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership
DCPrime BV, a clinical stage company developing dendritic cell vaccines to treat cancer, and apceth Biopharma GmbH, an established contract manufacturing organization in the...
Press Releases
Nanobiotix Completes Patient Inclusion for Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma
NANOBIOTIX , a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced that it has completed patient inclusion for the...
Packaging & Labelling
New Unrivalled Capabilities Take GC-MS to the Next Level of Performance
Updated with new capabilities in high resolution accurate mass (HRAM) GC-MS, the Thermo Scientific Orbitrap GC-MS systems now give users across metabolomics, food safety,...
Articles
Nativisโ platform aims to transform disease treatment on a global scale โ โa symphony of curesโ
In late 2015, I was approached by the board of Nativis, Inc.to take on the leadership of the company, by then a 13-year-old โstartup.โ
I...
News
Medley Genomics and Transformative AI Selected as Winners in the 2017 Pistoia Alliance Presidentโs Startup Challenge
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the winners...
News
The Netherlands Cancer Institute Awarded Funding to Apply Molecular Imaging Technology to Prostate Cancer Surgery
The Netherlands Cancer Institute (NKI) announced that it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular...
Drug Research
ANTABIO Raises โฌ 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections
Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today the completion of a โฌ7.3M series. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















